GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » Median PS Value

Lonza Group (Lonza Group) Median PS Value : $42.41 (As of Apr. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Lonza Group Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Lonza Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $10.355. Lonza Group's 10-Year median PS Ratio is 4.0956. Therefore, the Median PS Value for today is $42.41.

As of today (2024-04-25), Lonza Group's share price is $56.50. Lonza Group's Median PS Value is $42.41. Therefore, Lonza Group's Price to Median PS Value for today is 1.33.

The historical rank and industry rank for Lonza Group's Median PS Value or its related term are showing as below:

LZAGY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.91   Med: 1.8   Max: 4.25
Current: 1.33

During the past 13 years, the highest Price to Median PS Value of Lonza Group was 4.25. The lowest was 0.91. And the median was 1.80.

LZAGY's Price-to-Median-PS-Value is ranked worse than
80.49% of 82 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.84 vs LZAGY: 1.33

Lonza Group Median PS Value Historical Data

The historical data trend for Lonza Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Median PS Value Chart

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.91 15.07 20.35 32.66 46.01

Lonza Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.35 - 32.66 - 46.01

Competitive Comparison of Lonza Group's Median PS Value

For the Diagnostics & Research subindustry, Lonza Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lonza Group's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Lonza Group's Price-to-Median-PS-Value falls into.



Lonza Group Median PS Value Calculation

Lonza Group's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=10.355*4.0956
=42.41

10-Year Median PS Ratio is 4.0956.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $10.355.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lonza Group  (OTCPK:LZAGY) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Lonza Group's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=56.50/42.41
=1.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lonza Group Median PS Value Related Terms

Thank you for viewing the detailed overview of Lonza Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Lonza Group (Lonza Group) Business Description

Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.